Psychiatry - Neuro/Psych Pharmacol News & Articles

21 Low-Dose Manic Switch and High-Dose Antimanic Effect and Extrapyramidal Symptoms by Aripiprazole in a Single Bipolar Patient American Journal of Therapeutics, May 17, 2013

22 Curcumin as an Add-On to Antidepressive Treatment: A Randomized, Double-Blind, Placebo-Controlled, Pilot Clinical Study Clinical Neuropharmacology, May 16, 2013    Clinical Article

23 Amphetamine, past and present - a pharmacological and clinical perspective Journal of Psychopharmacology, May 16, 2013    Review Article    Clinical Article

24 Effectiveness and Safety of Memantine Treatment for Alzheimers Disease Journal of Alzheimer’s Disease, May 16, 2013    Clinical Article

25 Designing a Trial to Evaluate Potential Treatments for Apathy in Dementia: The Apathy in Dementia Methylphenidate Trial (ADMET) The American Journal of Geriatric Psychiatry, May 16, 2013    Clinical Article

26 Aripiprazole associated urine retention in a male schizophrenia patient General Hospital Psychiatry, May 16, 2013

27 Lamotrigine Abolished Aggression in a Patient With Treatment-Resistant Posttraumatic Stress Disorder Clinical Neuropharmacology, May 16, 2013

28 Fifty-two-week continuous abstinence rates of smokers being treated with varenicline versus nicotine replacement therapy Addiction, May 15, 2013    Clinical Article

29 Efficacy and safety of olanzapine for treatment of patients with bipolar depression: Japanese subpopulation analysis of a randomized, double-blind, placebo-controlled study Full Text BMC Psychiatry, May 15, 2013    Clinical Article

30 Benefits of combined cholinesterase inhibitor and memantine treatment in moderate-severe Alzheimers disease Alzheimer's & Dementia, May 14, 2013    Review Article    Clinical Article

31 Motivational incentives and methylphenidate enhance electrophysiological correlates of error monitoring in children with attention deficit/hyperactivity disorder Journal of Child Psychology and Psychiatry, May 14, 2013    Clinical Article

32 Biomarkers for Smoking Cessation Clinical Pharmacology & Therapeutics, May 14, 2013    Review Article

33 Working Memory Capacity Predicts Effects of Methylphenidate on Reversal Learning Neuropsychopharmacology, May 14, 2013    Clinical Article

34 Treatment of clozapine-induced priapism by goserline acetate injection Therapeutic Advances in Psychopharmacology, May 14, 2013
Exclusive Author Commentary

35 Effects of repeated dosing with mirtazapine, trazodone, or placebo on driving performance and cognitive function in healthy volunteers Human Psychopharmacology: Clinical and Experimental, May 13, 2013    Clinical Article

36 Areas of the Brain Modulated by Single-Dose Methylphenidate Treatment in Youth with ADHD During Task-Based fMRI: A Systematic Review Harvard Review of Psychiatry, May 13, 2013    Evidence Based Medicine    Review Article    Clinical Article

37 Antipsychotic augmentation of selective serotonin reuptake inhibitors in resistant tic-related obsessive-compulsive disorder in children and adolescents: A naturalistic comparative study Journal of Psychiatric Research, May 13, 2013    Clinical Article

38 Infliximab for Treatment-Resistant Depression Full Text First Report Managed Care, May 13, 2013

39 The Impact of Escitalopram on IL-2-Induced Neuroendocrine, Immune, and Behavioral Changes in Patients with Malignant Melanoma: Preliminary Findings Neuropsychopharmacology, May 13, 2013

40 Long Acting Injectable Aripiprazole Clinical Schizophrenia & Related Psychoses, May 10, 2013    Clinical Article

1 Nidotherapy for people with schizophrenia Cochrane Reviews, April 11, 2013    Evidence Based Medicine

2 Augmentation with Atypical Antipsychotics for Depression: A Review of Evidence-Based Support from the Medical Literature Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, March 13, 2013    Evidence Based Medicine

3 Long-term safety and tolerability of aripiprazole once-monthly in maintenance treatment of patients with schizophrenia International Clinical Psychopharmacology, April 25, 2013

4 Risperidone, quetiapine, and olanzapine adjunctive treatments in major depression with psychotic features: a comparative study Neuropsychiatric Disease and Treatment, April 18, 2013    Free full text

5 Effectiveness of lurasidone vs. quetiapine XR for relapse prevention in schizophrenia: A 12-month, double-blind, noninferiority study Schizophrenia Research, April 16, 2013

6 A randomized add-on trial of high-dose d -cycloserine for treatment-resistant depression International Journal of Neuropsychopharmacology, March 6, 2013

7 Full central neurokinin-1 receptor blockade is required for efficacy in depression: evidence from orvepitant clinical studies Journal of Psychopharmacology, April 8, 2013

8 The sertraline versus electrical current therapy for treating depression clinical study (SELECT-TDCS): results of the crossover and follow-up phases Depression and Anxiety, April 29, 2013

9 Add-on fluvoxamine treatment for schizophrenia: an updated meta-analysis of randomized controlled trials European Archives of Psychiatry and Clinical Neuroscience, April 22, 2013    Evidence Based Medicine

10 A Randomized Trial on the Acute and Steady-State Effects of a New Antidepressant, Vortioxetine, on Actual Driving and Cognition Clinical Pharmacology & Therapeutics, April 24, 2013

11 Guidance for the Discontinuation or Switching of Antidepressant Therapies in Adults Journal of Pharmacy Practice, March 26, 2013    Clinical Guideline

12 The effect of zonisamide on antipsychotic-associated weight gain in patients with schizophrenia: A randomized, double-blind, placebo-controlled clinical trial Schizophrenia Research, April 17, 2013

13 A randomised, double-blind, placebo-controlled, efficacy study of nalmefene, as-needed use, in patients with alcohol dependence European Neuropsychopharmacology, April 12, 2013

14 Reboxetine Treatment for Autistic Spectrum Disorder of Pediatric Patients With Depressive and Inattentive/Hyperactive Symptoms: An Open-Label Trial Clinical Neuropharmacology, April 5, 2013

15 Efficacy of the novel antidepressant agomelatine for anxiety symptoms in major depression Human Psychopharmacology: Clinical and Experimental, March 28, 2013

16 Additional ECT increases BDNF-levels in patients suffering from major depressive disorders compared to patients treated with citalopram only Journal of Psychiatric Research, April 15, 2013

17 Memantine as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial International Journal of Neuropsychopharmacology, April 2, 2013
Exclusive Author Commentary

18 Asenapine effects on individual Young Mania Rating Scale items in bipolar disorder patients with acute manic or mixed episodes: a pooled analysis Neuropsychiatric Disease and Treatment, April 9, 2013    Free full text

19 The Fetal Safety of Fluoxetine: A Systematic Review and Meta-Analysis Journal of Obstetrics and Gynaecology Canada, April 11, 2013    Free full text    Evidence Based Medicine    Review Article

20 A double-blind, placebo-controlled study of adjunctive calcitonin nasal spray in acute refractory mania Bipolar Disorders, April 2, 2013